Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Democratic Republic of Congo
Democratic Republic of Congo: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 63.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Democratic Republic of Congo, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Democratic Republic of Congo is 63.0%, measured in 2025.
The figure is down 1.6% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Democratic Republic of Congo peaked at 72.0% in 2019 and was at its lowest, 0.0%, in 2008.
That places Democratic Republic of Congo 142nd out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 44.9% | 0.0% | 72.0% | 10 |
| 2020s | 63.5% | 59.0% | 69.0% | 6 |
Countries ranked near Democratic Republic of Congo
- 140 South Africa 65.0% compare
- 141 Benin 64.0% compare
- 142 Afghanistan 63.0% compare
- 144 Marshall Islands 62.0% compare
- 144 Laos 62.0% compare
- 144 Nigeria 62.0% compare
More health data for Democratic Republic of Congo
- Un projection of annual infant deaths 133,650 (2100)
- Heat deaths vs projected death rates 821.4 (2090)
- Deaths in armed conflicts by region 528 (2026)
- Deaths in armed conflicts by country 528 (2026)
- Age population, age 08, male, interpolated 1.66 million (2025)
- Population, male 49.6% (2025)
- Population ages 15-64, female 29.09 million (2025)
- Population ages 0-14, total 51.85 million (2025)
- Age population, age 06, female, interpolated 1.78 million (2025)
- Age population, age 06, male, interpolated 1.79 million (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Democratic Republic of Congo?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Democratic Republic of Congo was 63.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Democratic Republic of Congo?
- The highest recorded value was 72.0% in 2019.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Democratic Republic of Congo?
- The lowest recorded value was 0.0% in 2008.
- How does Democratic Republic of Congo rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Democratic Republic of Congo ranks 142nd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Democratic Republic of Congo?
- Over the last ten years it is down 1.6%. The long-run trend across the full record is volatile.
- Where does this Democratic Republic of Congo data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).